These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18181032)

  • 1. Intravenous levetiracetam terminates refractory focal status epilepticus.
    Abend NS; Florance N; Finkel RS; Licht DJ; Dlugos DJ
    Neurocrit Care; 2009; 10(1):83-6. PubMed ID: 18181032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Termination of complex partial status epilepticus by intravenous levetiracetam.
    Schulze-Bonhage A; Hefft S; Oehl B
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):931-3. PubMed ID: 17353254
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy.
    Cilio MR; Bianchi R; Balestri M; Onofri A; Giovannini S; Di Capua M; Vigevano F
    Epilepsy Res; 2009 Sep; 86(1):66-71. PubMed ID: 19520548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series.
    Gámez-Leyva G; Aristín JL; Fernández E; Pascual J
    CNS Drugs; 2009 Nov; 23(11):983-7. PubMed ID: 19845418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
    Zaccara G; Giorgi FS; Amantini A; Giannasi G; Campostrini R; Giovannelli F; Paganini M; Nazerian P;
    Acta Neurol Scand; 2018 Jun; 137(6):618-622. PubMed ID: 29624640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of levetiracetam in refractory status epilepticus.
    Patel NC; Landan IR; Levin J; Szaflarski J; Wilner AN
    Seizure; 2006 Apr; 15(3):137-41. PubMed ID: 16426869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.
    Lyttle MD; Gamble C; Messahel S; Hickey H; Iyer A; Woolfall K; Humphreys A; Bacon NEA; Roper L; Babl FE; Dalziel SR; Ryan M; Appleton RE;
    Trials; 2017 Jun; 18(1):283. PubMed ID: 28629473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF; Crisp ED; Kayani S; Rajab H
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
    Khongkhatithum C; Thampratankul L; Wiwattanadittakul N; Visudtibhan A
    Eur J Paediatr Neurol; 2015 Jul; 19(4):429-34. PubMed ID: 25800343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
    İşgüder R; Güzel O; Ceylan G; Yılmaz Ü; Ağın H
    J Child Neurol; 2016 Aug; 31(9):1120-6. PubMed ID: 27080042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of absence status epilepticus by low-dose intravenous levetiracetam.
    Altenmüller DM; Kühn A; Surges R; Schulze-Bonhage A
    Epilepsia; 2008 Jul; 49(7):1289-90. PubMed ID: 18638286
    [No Abstract]   [Full Text] [Related]  

  • 13. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
    Eue S; Grumbt M; Müller M; Schulze A
    Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study.
    Aiguabella M; Falip M; Villanueva V; de la Peña P; Molins A; Garcia-Morales I; Saiz RA; Pardo J; Tortosa D; Sansa G; Miró J
    Seizure; 2011 Jan; 20(1):60-4. PubMed ID: 21145758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we accept the status quo? Time for new trials in status epilepticus.
    Jackson MJ
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):490. PubMed ID: 18408086
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
    Atmaca MM; Orhan EK; Bebek N; Gurses C
    Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus.
    Kim JS; Lee JH; Ryu HW; Lim BC; Hwang H; Chae JH; Choi J; Kim KJ; Hwang YS; Kim H
    Pediatr Emerg Care; 2014 Aug; 30(8):525-8. PubMed ID: 25062293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
    Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A
    Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IV levetiracetam in the management of non-convulsive status epilepticus.
    Farooq MU; Naravetla B; Majid A; Gupta R; Pysh JJ; Kassab MY
    Neurocrit Care; 2007; 7(1):36-9. PubMed ID: 17657655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.